Christine Williams

$395,996.12asActing President and Head, Implementation Science

Employed by Ontario Institute For Cancer Research in 2025, according to Government of Ontario public salary records.

Position

Acting President and Head, Implementation Science

Employer

Ontario Institute For Cancer Research

Salary Information

Historical salary and taxable benefits from 2016 to 2025.

YearPositionSalaryBenefitsPerformance
2025
Acting President and Head, Implementation Science
$395,996.12
$1,477.44
8.75%
2024
Executive Vice President and Head, Implementation Science
$364,149.86
$1,477.44
1.15%
2023
Executive Vice President and Head, Implementation Science
$359,996.00
$1,462.86
2022
Executive Vice President and Head, Implementation Science
$359,996.00
$1,375.38
16.2%
2021
Executive Vice President and Head, Implementation Science
$309,799.89
$1,244.16
3.13%
2020
Deputy Director
$300,402.40
$1,237.68
2019
Deputy Director
$300,402.40
$1,218.24
1.67%
2018
Deputy Director
$295,469.64
$1,218.24
8.95%
2017
Deputy Director
$271,200.41
$1,218.24
39.46%
2016
Deputy Director
$194,463.96
$812.16

Christine Williams earned $395,996.12 as Acting President and Head, Implementation Science at Ontario Institute For Cancer Research in 2025, according to the Ontario Sunshine List. This represents a 8.75% increase over the previous year's reported salary. Christine Williams has appeared on the Ontario Sunshine List 10 times between 2016 and 2025, with reported earnings peaking at $395,996.12 in 2025. In addition to salary, $1,477.44 in taxable benefits was disclosed for 2025. Ontario Institute For Cancer Research reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.

Top earning Acting President and Head, Implementation Sciences in Ontario Institute For Cancer Research

NameSalary
Christine Williams$395,996.12
NameSalary
Leslie Radvanyi
President and Scientific Director
$539,745.00
Lincoln Stein
Acting Scientific Director and Head, Adaptive Oncology
$383,286.80
Jared T. Simpson
Interim Scientific Director and Principal Investigator
$331,897.15
David E. Uehling
Interim Scientific Director, Therapeutic Innovation and Drug Discovery
$329,520.45
Peter Goodhand
Executive Lead
$321,484.80
Jeanette Dias D'Souza
Senior Vice President, Group Chief Financial Officer
$319,995.00